Monday , September 23 2019
Home / Cato Liberty / CDC Extols the Benefits of Naloxone⁠—Time to Make it OTC

CDC Extols the Benefits of Naloxone⁠—Time to Make it OTC

Summary:
Yesterday the Centers for Disease Control and Prevention reported that while naloxone prescriptions have increase 106 percent in the last year, the increase has been spotty, and largely confined to urban areas. Columbia University epidemiologist Katherine Keyes told the Los Angeles Times that she suspects the increase in naloxone distribution is contributing to what appears to be a stabilization of the opioid-related overdose rate in 2018. I agree, as I have written here.  Distributing the opioid overdose antidote naloxone is one harm reduction measure that has gained widespread acceptance among policy makers, despite a few naysayers who believe making naloxone available presents a moral hazard and may encourage non-medical drug use. Dr. Anne Schuchat, the CDC Principal Deputy

Topics:
Jeffrey A. Singer considers the following as important:

This could be interesting, too:

Wolf Richter writes Asset Class of Vintage Cars Drops into Bear Market, Down by More than in 2008/2009

Tyler Durden writes Insane And Ill-Advised: Trump’s Future War With Iran, Part 2

Tyler Durden writes “What Were You Like At 17?”: Bill Maher Defends Brett Kavanaugh In Fiery Exchange With Guest

Tyler Durden writes South Korean Exports Collapse 21% – Biggest Drop In A Decade

Yesterday the Centers for Disease Control and Prevention reported that while naloxone prescriptions have increase 106 percent in the last year, the increase has been spotty, and largely confined to urban areas. Columbia University epidemiologist Katherine Keyes told the Los Angeles Times that she suspects the increase in naloxone distribution is contributing to what appears to be a stabilization of the opioid-related overdose rate in 2018. I agree, as I have written here

Distributing the opioid overdose antidote naloxone is one harm reduction measure that has gained widespread acceptance among policy makers, despite a few naysayers who believe making naloxone available presents a moral hazard and may encourage non-medical drug use.

Dr. Anne Schuchat, the CDC Principal Deputy Director, told reporters she also believes naloxone contributed to the stabilization, and that naloxone needs to be more much widely distributed and employed. She told reporters,”If each person with a high-dose opioid prescription were offered naloxone, nearly 9 million prescriptions for naloxone could have been dispensed in 2018.”

Last year the Surgeon General  issued a Public Health Advisory encouraging Americans to learn more about the drug and to consider carrying the drug with them if they or someone they know use high-dose opioids. 

As I have written here, a good way to help accelerate the dissemination of naloxone would be for the Food and Drug Administration to make it truly an over-the-counter drug. In the recent past, the FDA Commissioner seemed very amenable to the idea. It is time to take that next step.

Leave a Reply

Your email address will not be published. Required fields are marked *